Defining Cure Through Targeted Therapeutics
AlterRNA Therapeutics is a patient-driven biotech company founded by a father after his child was diagnosed with MPAN. We are building collaborative, affordable research and treatment development pathways for rare genetic disorders.
Join Our Community
Transforming Lives Through RNA Science
AlterRNA is dedicated to developing next-generation RNA therapeutics that address the underlying genetic causes of disease. AlterRNA was founded to help close the gap between genetic diagnosis and therapeutic development for rare diseases by connecting patient need, RNA science, clinical insight, and collaborative development.
Precision Medicine
Precisely targeting specific genetic mutations
Innovation
Pioneering novel RNA modification technologies
Patient-Centric
Driven by the needs of patients and their families
Scientific Excellence
Committed to rigorous research and development
Addressing Critical Unmet Needs
Our pipeline targets rare genetic diseases across multiple therapeutic areas, bringing hope to patients with limited treatment options.
Development Pipeline
AlterRNA is dedicated to developing next-generation RNA therapeutics
Delivery Candidate Systems
Human BBB Platform (Organ-Specific Delivery)
This research is for Human BBB platform for organ specific…
MPAN-C19orf12 Therapeutics Master
Novel approach to treating lysosomal storage diseases through targeted mRNA…
Collaborative Knowledge Exchange
Join our secure network of researchers, clinicians, and partners to share insights, discuss methodologies, and advance the field of RNA therapeutics together.
Invest in the Future of Bio-Medicine
AlterRNA offers unique opportunities for investors to fund high-potential therapeutic projects with full transparency and data-backed milestones.
$
Research Funded
+
Clinical Stage Assets
+
Partner Institutions
X
Yearly Growth